AI assistant
Sending…
CME GROUP INC. — Director's Dealing 2022
Mar 14, 2022
29871_dirs_2022-03-14_bdb8a870-b68d-40ad-a940-f2af5bdc81cc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2022-03-11
Reporting Person: CRONIN KATHLEEN M (Sr MD Gen Counsel & Corp Secr)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-11 | Common Stock Class A | S | 4000 | $227.153 | Disposed | 40368 | Direct |
| 2022-03-11 | Common Stock Class A | G | 283 | — | Disposed | 40085 | Direct |
Footnotes
F1: On March 11, 2022, Ms. Cronin sold an aggregate of 4,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $227.10 to $227.264. The Company maintains a record of the transaction and copies will be provided upon request.
F2: This transaction involved a gift of securities from the reporting person to a charitable organization.
More from CME GROUP INC.
Proxy Solicitation & Information Statement
2026
May 19
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
Apr 24
Earnings Release
2026
Apr 22
Major Shareholding Notification
2026
Mar 26
Remuneration Information
2026
Mar 23
Annual Report
2026
Mar 23
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 19
Regulatory Filings
2026
Mar 17